Global GLP-1 Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global GLP-1 Drugs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
GLP-1drugs,also known as GLP-1 receptor agonists,which mimic the action of GLP-1 by binding to GLP-1 receptors on pancreatic beta cells,promoting insulin release and reducing glucagon secretion.This helps lower blood sugar levels after meals,leading to improved glycemic controlIn addition to their glucose-lowering effects,GLP-1 receptor agonists have been shown to promote weight loss and may have cardiovascular benefits.
This report is a detailed and comprehensive analysis for global GLP-1 Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
GLP-1drugs,also known as GLP-1 receptor agonists,which mimic the action of GLP-1 by binding to GLP-1 receptors on pancreatic beta cells,promoting insulin release and reducing glucagon secretion.This helps lower blood sugar levels after meals,leading to improved glycemic controlIn addition to their glucose-lowering effects,GLP-1 receptor agonists have been shown to promote weight loss and may have cardiovascular benefits.
This report is a detailed and comprehensive analysis for global GLP-1 Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
- Global GLP-1 Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
- Global GLP-1 Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
- Global GLP-1 Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
- Global GLP-1 Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for GLP-1 Drugs
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
- This report profiles key players in the global GLP-1 Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, GSK, Shanghai Renhui Biopharmaceutical, Huadong Medicine, Sino Biopharm, etc.
- This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
GLP-1 Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- Dulaglutide
- Exenatide
- Liraglutide
- Lixisenatide
- Semaglutide
- Beinaglutide
- Albiglutide
Market segment by Application
- Type 2 Diabetes
- Obesity
Major players covered
- Novo Nordisk
- Eli Lilly
- AstraZeneca
- Sanofi
- GSK
- Shanghai Renhui Biopharmaceutical
- Huadong Medicine
- Sino Biopharm
Market segment by region, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
- Chapter 1, to describe GLP-1 Drugs product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top manufacturers of GLP-1 Drugs, with price, sales quantity, revenue, and global market share of GLP-1 Drugs from 2021 to 2026.
- Chapter 3, the GLP-1 Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
- Chapter 4, the GLP-1 Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
- Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and GLP-1 Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
- Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
- Chapter 13, the key raw materials and key suppliers, and industry chain of GLP-1 Drugs.
- Chapter 14 and 15, to describe GLP-1 Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global GLP-1 Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Dulaglutide
1.3.3 Exenatide
1.3.4 Liraglutide
1.3.5 Lixisenatide
1.3.6 Semaglutide
1.3.7 Beinaglutide
1.3.8 Albiglutide
1.4 Market Analysis by Application
1.4.1 Overview: Global GLP-1 Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Type 2 Diabetes
1.4.3 Obesity
1.5 Global GLP-1 Drugs Market Size & Forecast
1.5.1 Global GLP-1 Drugs Consumption Value (2021 & 2025 & 2032)
1.5.2 Global GLP-1 Drugs Sales Quantity (2021-2032)
1.5.3 Global GLP-1 Drugs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk GLP-1 Drugs Product and Services
2.1.4 Novo Nordisk GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Novo Nordisk Recent Developments/Updates
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly GLP-1 Drugs Product and Services
2.2.4 Eli Lilly GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Eli Lilly Recent Developments/Updates
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca GLP-1 Drugs Product and Services
2.3.4 AstraZeneca GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 AstraZeneca Recent Developments/Updates
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi GLP-1 Drugs Product and Services
2.4.4 Sanofi GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Sanofi Recent Developments/Updates
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business
2.5.3 GSK GLP-1 Drugs Product and Services
2.5.4 GSK GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 GSK Recent Developments/Updates
2.6 Shanghai Renhui Biopharmaceutical
2.6.1 Shanghai Renhui Biopharmaceutical Details
2.6.2 Shanghai Renhui Biopharmaceutical Major Business
2.6.3 Shanghai Renhui Biopharmaceutical GLP-1 Drugs Product and Services
2.6.4 Shanghai Renhui Biopharmaceutical GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Shanghai Renhui Biopharmaceutical Recent Developments/Updates
2.7 Huadong Medicine
2.7.1 Huadong Medicine Details
2.7.2 Huadong Medicine Major Business
2.7.3 Huadong Medicine GLP-1 Drugs Product and Services
2.7.4 Huadong Medicine GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Huadong Medicine Recent Developments/Updates
2.8 Sino Biopharm
2.8.1 Sino Biopharm Details
2.8.2 Sino Biopharm Major Business
2.8.3 Sino Biopharm GLP-1 Drugs Product and Services
2.8.4 Sino Biopharm GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Sino Biopharm Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: GLP-1 DRUGS BY MANUFACTURER
3.1 Global GLP-1 Drugs Sales Quantity by Manufacturer (2021-2026)
3.2 Global GLP-1 Drugs Revenue by Manufacturer (2021-2026)
3.3 Global GLP-1 Drugs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of GLP-1 Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 GLP-1 Drugs Manufacturer Market Share in 2025
3.4.3 Top 6 GLP-1 Drugs Manufacturer Market Share in 2025
3.5 GLP-1 Drugs Market: Overall Company Footprint Analysis
3.5.1 GLP-1 Drugs Market: Region Footprint
3.5.2 GLP-1 Drugs Market: Company Product Type Footprint
3.5.3 GLP-1 Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global GLP-1 Drugs Market Size by Region
4.1.1 Global GLP-1 Drugs Sales Quantity by Region (2021-2032)
4.1.2 Global GLP-1 Drugs Consumption Value by Region (2021-2032)
4.1.3 Global GLP-1 Drugs Average Price by Region (2021-2032)
4.2 North America GLP-1 Drugs Consumption Value (2021-2032)
4.3 Europe GLP-1 Drugs Consumption Value (2021-2032)
4.4 Asia-Pacific GLP-1 Drugs Consumption Value (2021-2032)
4.5 South America GLP-1 Drugs Consumption Value (2021-2032)
4.6 Middle East & Africa GLP-1 Drugs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global GLP-1 Drugs Sales Quantity by Type (2021-2032)
5.2 Global GLP-1 Drugs Consumption Value by Type (2021-2032)
5.3 Global GLP-1 Drugs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global GLP-1 Drugs Sales Quantity by Application (2021-2032)
6.2 Global GLP-1 Drugs Consumption Value by Application (2021-2032)
6.3 Global GLP-1 Drugs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America GLP-1 Drugs Sales Quantity by Type (2021-2032)
7.2 North America GLP-1 Drugs Sales Quantity by Application (2021-2032)
7.3 North America GLP-1 Drugs Market Size by Country
7.3.1 North America GLP-1 Drugs Sales Quantity by Country (2021-2032)
7.3.2 North America GLP-1 Drugs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe GLP-1 Drugs Sales Quantity by Type (2021-2032)
8.2 Europe GLP-1 Drugs Sales Quantity by Application (2021-2032)
8.3 Europe GLP-1 Drugs Market Size by Country
8.3.1 Europe GLP-1 Drugs Sales Quantity by Country (2021-2032)
8.3.2 Europe GLP-1 Drugs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific GLP-1 Drugs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific GLP-1 Drugs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific GLP-1 Drugs Market Size by Region
9.3.1 Asia-Pacific GLP-1 Drugs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific GLP-1 Drugs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America GLP-1 Drugs Sales Quantity by Type (2021-2032)
10.2 South America GLP-1 Drugs Sales Quantity by Application (2021-2032)
10.3 South America GLP-1 Drugs Market Size by Country
10.3.1 South America GLP-1 Drugs Sales Quantity by Country (2021-2032)
10.3.2 South America GLP-1 Drugs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa GLP-1 Drugs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa GLP-1 Drugs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa GLP-1 Drugs Market Size by Country
11.3.1 Middle East & Africa GLP-1 Drugs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa GLP-1 Drugs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 GLP-1 Drugs Market Drivers
12.2 GLP-1 Drugs Market Restraints
12.3 GLP-1 Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of GLP-1 Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of GLP-1 Drugs
13.3 GLP-1 Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 GLP-1 Drugs Typical Distributors
14.3 GLP-1 Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global GLP-1 Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Dulaglutide
1.3.3 Exenatide
1.3.4 Liraglutide
1.3.5 Lixisenatide
1.3.6 Semaglutide
1.3.7 Beinaglutide
1.3.8 Albiglutide
1.4 Market Analysis by Application
1.4.1 Overview: Global GLP-1 Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Type 2 Diabetes
1.4.3 Obesity
1.5 Global GLP-1 Drugs Market Size & Forecast
1.5.1 Global GLP-1 Drugs Consumption Value (2021 & 2025 & 2032)
1.5.2 Global GLP-1 Drugs Sales Quantity (2021-2032)
1.5.3 Global GLP-1 Drugs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk GLP-1 Drugs Product and Services
2.1.4 Novo Nordisk GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Novo Nordisk Recent Developments/Updates
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly GLP-1 Drugs Product and Services
2.2.4 Eli Lilly GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Eli Lilly Recent Developments/Updates
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca GLP-1 Drugs Product and Services
2.3.4 AstraZeneca GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 AstraZeneca Recent Developments/Updates
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi GLP-1 Drugs Product and Services
2.4.4 Sanofi GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Sanofi Recent Developments/Updates
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business
2.5.3 GSK GLP-1 Drugs Product and Services
2.5.4 GSK GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 GSK Recent Developments/Updates
2.6 Shanghai Renhui Biopharmaceutical
2.6.1 Shanghai Renhui Biopharmaceutical Details
2.6.2 Shanghai Renhui Biopharmaceutical Major Business
2.6.3 Shanghai Renhui Biopharmaceutical GLP-1 Drugs Product and Services
2.6.4 Shanghai Renhui Biopharmaceutical GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Shanghai Renhui Biopharmaceutical Recent Developments/Updates
2.7 Huadong Medicine
2.7.1 Huadong Medicine Details
2.7.2 Huadong Medicine Major Business
2.7.3 Huadong Medicine GLP-1 Drugs Product and Services
2.7.4 Huadong Medicine GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Huadong Medicine Recent Developments/Updates
2.8 Sino Biopharm
2.8.1 Sino Biopharm Details
2.8.2 Sino Biopharm Major Business
2.8.3 Sino Biopharm GLP-1 Drugs Product and Services
2.8.4 Sino Biopharm GLP-1 Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Sino Biopharm Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: GLP-1 DRUGS BY MANUFACTURER
3.1 Global GLP-1 Drugs Sales Quantity by Manufacturer (2021-2026)
3.2 Global GLP-1 Drugs Revenue by Manufacturer (2021-2026)
3.3 Global GLP-1 Drugs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of GLP-1 Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 GLP-1 Drugs Manufacturer Market Share in 2025
3.4.3 Top 6 GLP-1 Drugs Manufacturer Market Share in 2025
3.5 GLP-1 Drugs Market: Overall Company Footprint Analysis
3.5.1 GLP-1 Drugs Market: Region Footprint
3.5.2 GLP-1 Drugs Market: Company Product Type Footprint
3.5.3 GLP-1 Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global GLP-1 Drugs Market Size by Region
4.1.1 Global GLP-1 Drugs Sales Quantity by Region (2021-2032)
4.1.2 Global GLP-1 Drugs Consumption Value by Region (2021-2032)
4.1.3 Global GLP-1 Drugs Average Price by Region (2021-2032)
4.2 North America GLP-1 Drugs Consumption Value (2021-2032)
4.3 Europe GLP-1 Drugs Consumption Value (2021-2032)
4.4 Asia-Pacific GLP-1 Drugs Consumption Value (2021-2032)
4.5 South America GLP-1 Drugs Consumption Value (2021-2032)
4.6 Middle East & Africa GLP-1 Drugs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global GLP-1 Drugs Sales Quantity by Type (2021-2032)
5.2 Global GLP-1 Drugs Consumption Value by Type (2021-2032)
5.3 Global GLP-1 Drugs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global GLP-1 Drugs Sales Quantity by Application (2021-2032)
6.2 Global GLP-1 Drugs Consumption Value by Application (2021-2032)
6.3 Global GLP-1 Drugs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America GLP-1 Drugs Sales Quantity by Type (2021-2032)
7.2 North America GLP-1 Drugs Sales Quantity by Application (2021-2032)
7.3 North America GLP-1 Drugs Market Size by Country
7.3.1 North America GLP-1 Drugs Sales Quantity by Country (2021-2032)
7.3.2 North America GLP-1 Drugs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe GLP-1 Drugs Sales Quantity by Type (2021-2032)
8.2 Europe GLP-1 Drugs Sales Quantity by Application (2021-2032)
8.3 Europe GLP-1 Drugs Market Size by Country
8.3.1 Europe GLP-1 Drugs Sales Quantity by Country (2021-2032)
8.3.2 Europe GLP-1 Drugs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific GLP-1 Drugs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific GLP-1 Drugs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific GLP-1 Drugs Market Size by Region
9.3.1 Asia-Pacific GLP-1 Drugs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific GLP-1 Drugs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America GLP-1 Drugs Sales Quantity by Type (2021-2032)
10.2 South America GLP-1 Drugs Sales Quantity by Application (2021-2032)
10.3 South America GLP-1 Drugs Market Size by Country
10.3.1 South America GLP-1 Drugs Sales Quantity by Country (2021-2032)
10.3.2 South America GLP-1 Drugs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa GLP-1 Drugs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa GLP-1 Drugs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa GLP-1 Drugs Market Size by Country
11.3.1 Middle East & Africa GLP-1 Drugs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa GLP-1 Drugs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 GLP-1 Drugs Market Drivers
12.2 GLP-1 Drugs Market Restraints
12.3 GLP-1 Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of GLP-1 Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of GLP-1 Drugs
13.3 GLP-1 Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 GLP-1 Drugs Typical Distributors
14.3 GLP-1 Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global GLP-1 Drugs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global GLP-1 Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk GLP-1 Drugs Product and Services
Table 6. Novo Nordisk GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Novo Nordisk Recent Developments/Updates
Table 8. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 9. Eli Lilly Major Business
Table 10. Eli Lilly GLP-1 Drugs Product and Services
Table 11. Eli Lilly GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Eli Lilly Recent Developments/Updates
Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca Major Business
Table 15. AstraZeneca GLP-1 Drugs Product and Services
Table 16. AstraZeneca GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. AstraZeneca Recent Developments/Updates
Table 18. Sanofi Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi GLP-1 Drugs Product and Services
Table 21. Sanofi GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Sanofi Recent Developments/Updates
Table 23. GSK Basic Information, Manufacturing Base and Competitors
Table 24. GSK Major Business
Table 25. GSK GLP-1 Drugs Product and Services
Table 26. GSK GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. GSK Recent Developments/Updates
Table 28. Shanghai Renhui Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Shanghai Renhui Biopharmaceutical Major Business
Table 30. Shanghai Renhui Biopharmaceutical GLP-1 Drugs Product and Services
Table 31. Shanghai Renhui Biopharmaceutical GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Shanghai Renhui Biopharmaceutical Recent Developments/Updates
Table 33. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 34. Huadong Medicine Major Business
Table 35. Huadong Medicine GLP-1 Drugs Product and Services
Table 36. Huadong Medicine GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Huadong Medicine Recent Developments/Updates
Table 38. Sino Biopharm Basic Information, Manufacturing Base and Competitors
Table 39. Sino Biopharm Major Business
Table 40. Sino Biopharm GLP-1 Drugs Product and Services
Table 41. Sino Biopharm GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Sino Biopharm Recent Developments/Updates
Table 43. Global GLP-1 Drugs Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 44. Global GLP-1 Drugs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 45. Global GLP-1 Drugs Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 46. Market Position of Manufacturers in GLP-1 Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 47. Head Office and GLP-1 Drugs Production Site of Key Manufacturer
Table 48. GLP-1 Drugs Market: Company Product Type Footprint
Table 49. GLP-1 Drugs Market: Company Product Application Footprint
Table 50. GLP-1 Drugs New Market Entrants and Barriers to Market Entry
Table 51. GLP-1 Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global GLP-1 Drugs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 53. Global GLP-1 Drugs Sales Quantity by Region (2021-2026) & (K Units)
Table 54. Global GLP-1 Drugs Sales Quantity by Region (2027-2032) & (K Units)
Table 55. Global GLP-1 Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 56. Global GLP-1 Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 57. Global GLP-1 Drugs Average Price by Region (2021-2026) & (US$/Unit)
Table 58. Global GLP-1 Drugs Average Price by Region (2027-2032) & (US$/Unit)
Table 59. Global GLP-1 Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 60. Global GLP-1 Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 61. Global GLP-1 Drugs Consumption Value by Type (2021-2026) & (USD Million)
Table 62. Global GLP-1 Drugs Consumption Value by Type (2027-2032) & (USD Million)
Table 63. Global GLP-1 Drugs Average Price by Type (2021-2026) & (US$/Unit)
Table 64. Global GLP-1 Drugs Average Price by Type (2027-2032) & (US$/Unit)
Table 65. Global GLP-1 Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 66. Global GLP-1 Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 67. Global GLP-1 Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 68. Global GLP-1 Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 69. Global GLP-1 Drugs Average Price by Application (2021-2026) & (US$/Unit)
Table 70. Global GLP-1 Drugs Average Price by Application (2027-2032) & (US$/Unit)
Table 71. North America GLP-1 Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 72. North America GLP-1 Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 73. North America GLP-1 Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 74. North America GLP-1 Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 75. North America GLP-1 Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 76. North America GLP-1 Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 77. North America GLP-1 Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 78. North America GLP-1 Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 79. Europe GLP-1 Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 80. Europe GLP-1 Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 81. Europe GLP-1 Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 82. Europe GLP-1 Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 83. Europe GLP-1 Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 84. Europe GLP-1 Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 85. Europe GLP-1 Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 86. Europe GLP-1 Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 87. Asia-Pacific GLP-1 Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific GLP-1 Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 89. Asia-Pacific GLP-1 Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 90. Asia-Pacific GLP-1 Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 91. Asia-Pacific GLP-1 Drugs Sales Quantity by Region (2021-2026) & (K Units)
Table 92. Asia-Pacific GLP-1 Drugs Sales Quantity by Region (2027-2032) & (K Units)
Table 93. Asia-Pacific GLP-1 Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific GLP-1 Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 95. South America GLP-1 Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 96. South America GLP-1 Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 97. South America GLP-1 Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 98. South America GLP-1 Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 99. South America GLP-1 Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 100. South America GLP-1 Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 101. South America GLP-1 Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 102. South America GLP-1 Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 103. Middle East & Africa GLP-1 Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa GLP-1 Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 105. Middle East & Africa GLP-1 Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 106. Middle East & Africa GLP-1 Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 107. Middle East & Africa GLP-1 Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 108. Middle East & Africa GLP-1 Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 109. Middle East & Africa GLP-1 Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa GLP-1 Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 111. GLP-1 Drugs Raw Material
Table 112. Key Manufacturers of GLP-1 Drugs Raw Materials
Table 113. GLP-1 Drugs Typical Distributors
Table 114. GLP-1 Drugs Typical Customers
Table 1. Global GLP-1 Drugs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global GLP-1 Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk GLP-1 Drugs Product and Services
Table 6. Novo Nordisk GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Novo Nordisk Recent Developments/Updates
Table 8. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 9. Eli Lilly Major Business
Table 10. Eli Lilly GLP-1 Drugs Product and Services
Table 11. Eli Lilly GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Eli Lilly Recent Developments/Updates
Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca Major Business
Table 15. AstraZeneca GLP-1 Drugs Product and Services
Table 16. AstraZeneca GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. AstraZeneca Recent Developments/Updates
Table 18. Sanofi Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi GLP-1 Drugs Product and Services
Table 21. Sanofi GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Sanofi Recent Developments/Updates
Table 23. GSK Basic Information, Manufacturing Base and Competitors
Table 24. GSK Major Business
Table 25. GSK GLP-1 Drugs Product and Services
Table 26. GSK GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. GSK Recent Developments/Updates
Table 28. Shanghai Renhui Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Shanghai Renhui Biopharmaceutical Major Business
Table 30. Shanghai Renhui Biopharmaceutical GLP-1 Drugs Product and Services
Table 31. Shanghai Renhui Biopharmaceutical GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Shanghai Renhui Biopharmaceutical Recent Developments/Updates
Table 33. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 34. Huadong Medicine Major Business
Table 35. Huadong Medicine GLP-1 Drugs Product and Services
Table 36. Huadong Medicine GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Huadong Medicine Recent Developments/Updates
Table 38. Sino Biopharm Basic Information, Manufacturing Base and Competitors
Table 39. Sino Biopharm Major Business
Table 40. Sino Biopharm GLP-1 Drugs Product and Services
Table 41. Sino Biopharm GLP-1 Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Sino Biopharm Recent Developments/Updates
Table 43. Global GLP-1 Drugs Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 44. Global GLP-1 Drugs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 45. Global GLP-1 Drugs Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 46. Market Position of Manufacturers in GLP-1 Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 47. Head Office and GLP-1 Drugs Production Site of Key Manufacturer
Table 48. GLP-1 Drugs Market: Company Product Type Footprint
Table 49. GLP-1 Drugs Market: Company Product Application Footprint
Table 50. GLP-1 Drugs New Market Entrants and Barriers to Market Entry
Table 51. GLP-1 Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global GLP-1 Drugs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 53. Global GLP-1 Drugs Sales Quantity by Region (2021-2026) & (K Units)
Table 54. Global GLP-1 Drugs Sales Quantity by Region (2027-2032) & (K Units)
Table 55. Global GLP-1 Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 56. Global GLP-1 Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 57. Global GLP-1 Drugs Average Price by Region (2021-2026) & (US$/Unit)
Table 58. Global GLP-1 Drugs Average Price by Region (2027-2032) & (US$/Unit)
Table 59. Global GLP-1 Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 60. Global GLP-1 Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 61. Global GLP-1 Drugs Consumption Value by Type (2021-2026) & (USD Million)
Table 62. Global GLP-1 Drugs Consumption Value by Type (2027-2032) & (USD Million)
Table 63. Global GLP-1 Drugs Average Price by Type (2021-2026) & (US$/Unit)
Table 64. Global GLP-1 Drugs Average Price by Type (2027-2032) & (US$/Unit)
Table 65. Global GLP-1 Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 66. Global GLP-1 Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 67. Global GLP-1 Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 68. Global GLP-1 Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 69. Global GLP-1 Drugs Average Price by Application (2021-2026) & (US$/Unit)
Table 70. Global GLP-1 Drugs Average Price by Application (2027-2032) & (US$/Unit)
Table 71. North America GLP-1 Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 72. North America GLP-1 Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 73. North America GLP-1 Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 74. North America GLP-1 Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 75. North America GLP-1 Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 76. North America GLP-1 Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 77. North America GLP-1 Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 78. North America GLP-1 Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 79. Europe GLP-1 Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 80. Europe GLP-1 Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 81. Europe GLP-1 Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 82. Europe GLP-1 Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 83. Europe GLP-1 Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 84. Europe GLP-1 Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 85. Europe GLP-1 Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 86. Europe GLP-1 Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 87. Asia-Pacific GLP-1 Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific GLP-1 Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 89. Asia-Pacific GLP-1 Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 90. Asia-Pacific GLP-1 Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 91. Asia-Pacific GLP-1 Drugs Sales Quantity by Region (2021-2026) & (K Units)
Table 92. Asia-Pacific GLP-1 Drugs Sales Quantity by Region (2027-2032) & (K Units)
Table 93. Asia-Pacific GLP-1 Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific GLP-1 Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 95. South America GLP-1 Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 96. South America GLP-1 Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 97. South America GLP-1 Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 98. South America GLP-1 Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 99. South America GLP-1 Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 100. South America GLP-1 Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 101. South America GLP-1 Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 102. South America GLP-1 Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 103. Middle East & Africa GLP-1 Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa GLP-1 Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 105. Middle East & Africa GLP-1 Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 106. Middle East & Africa GLP-1 Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 107. Middle East & Africa GLP-1 Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 108. Middle East & Africa GLP-1 Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 109. Middle East & Africa GLP-1 Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa GLP-1 Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 111. GLP-1 Drugs Raw Material
Table 112. Key Manufacturers of GLP-1 Drugs Raw Materials
Table 113. GLP-1 Drugs Typical Distributors
Table 114. GLP-1 Drugs Typical Customers
LIST OF FIGURES
Figure 1. GLP-1 Drugs Picture
Figure 2. Global GLP-1 Drugs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global GLP-1 Drugs Revenue Market Share by Type in 2025
Figure 4. Dulaglutide Examples
Figure 5. Exenatide Examples
Figure 6. Liraglutide Examples
Figure 7. Lixisenatide Examples
Figure 8. Semaglutide Examples
Figure 9. Beinaglutide Examples
Figure 10. Albiglutide Examples
Figure 11. Albiglutide Examples
Figure 12. Global GLP-1 Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 13. Global GLP-1 Drugs Revenue Market Share by Application in 2025
Figure 14. Type 2 Diabetes Examples
Figure 15. Obesity Examples
Figure 16. Global GLP-1 Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 17. Global GLP-1 Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 18. Global GLP-1 Drugs Sales Quantity (2021-2032) & (K Units)
Figure 19. Global GLP-1 Drugs Price (2021-2032) & (US$/Unit)
Figure 20. Global GLP-1 Drugs Sales Quantity Market Share by Manufacturer in 2025
Figure 21. Global GLP-1 Drugs Revenue Market Share by Manufacturer in 2025
Figure 22. Producer Shipments of GLP-1 Drugs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 23. Top 3 GLP-1 Drugs Manufacturer (Revenue) Market Share in 2025
Figure 24. Top 6 GLP-1 Drugs Manufacturer (Revenue) Market Share in 2025
Figure 25. Global GLP-1 Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 26. Global GLP-1 Drugs Consumption Value Market Share by Region (2021-2032)
Figure 27. North America GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 30. South America GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 32. Global GLP-1 Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 33. Global GLP-1 Drugs Consumption Value Market Share by Type (2021-2032)
Figure 34. Global GLP-1 Drugs Average Price by Type (2021-2032) & (US$/Unit)
Figure 35. Global GLP-1 Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 36. Global GLP-1 Drugs Revenue Market Share by Application (2021-2032)
Figure 37. Global GLP-1 Drugs Average Price by Application (2021-2032) & (US$/Unit)
Figure 38. North America GLP-1 Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 39. North America GLP-1 Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 40. North America GLP-1 Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 41. North America GLP-1 Drugs Consumption Value Market Share by Country (2021-2032)
Figure 42. United States GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 43. Canada GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 44. Mexico GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 45. Europe GLP-1 Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 46. Europe GLP-1 Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 47. Europe GLP-1 Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 48. Europe GLP-1 Drugs Consumption Value Market Share by Country (2021-2032)
Figure 49. Germany GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 50. France GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 51. United Kingdom GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 52. Russia GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 53. Italy GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 54. Asia-Pacific GLP-1 Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 55. Asia-Pacific GLP-1 Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 56. Asia-Pacific GLP-1 Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 57. Asia-Pacific GLP-1 Drugs Consumption Value Market Share by Region (2021-2032)
Figure 58. China GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 59. Japan GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 60. South Korea GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 61. India GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 62. Southeast Asia GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 63. Australia GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 64. South America GLP-1 Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 65. South America GLP-1 Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 66. South America GLP-1 Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 67. South America GLP-1 Drugs Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa GLP-1 Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 71. Middle East & Africa GLP-1 Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 72. Middle East & Africa GLP-1 Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 73. Middle East & Africa GLP-1 Drugs Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 75. Egypt GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 77. South Africa GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 78. GLP-1 Drugs Market Drivers
Figure 79. GLP-1 Drugs Market Restraints
Figure 80. GLP-1 Drugs Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of GLP-1 Drugs in 2025
Figure 83. Manufacturing Process Analysis of GLP-1 Drugs
Figure 84. GLP-1 Drugs Industrial Chain
Figure 85. Sales Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. GLP-1 Drugs Picture
Figure 2. Global GLP-1 Drugs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global GLP-1 Drugs Revenue Market Share by Type in 2025
Figure 4. Dulaglutide Examples
Figure 5. Exenatide Examples
Figure 6. Liraglutide Examples
Figure 7. Lixisenatide Examples
Figure 8. Semaglutide Examples
Figure 9. Beinaglutide Examples
Figure 10. Albiglutide Examples
Figure 11. Albiglutide Examples
Figure 12. Global GLP-1 Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 13. Global GLP-1 Drugs Revenue Market Share by Application in 2025
Figure 14. Type 2 Diabetes Examples
Figure 15. Obesity Examples
Figure 16. Global GLP-1 Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 17. Global GLP-1 Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 18. Global GLP-1 Drugs Sales Quantity (2021-2032) & (K Units)
Figure 19. Global GLP-1 Drugs Price (2021-2032) & (US$/Unit)
Figure 20. Global GLP-1 Drugs Sales Quantity Market Share by Manufacturer in 2025
Figure 21. Global GLP-1 Drugs Revenue Market Share by Manufacturer in 2025
Figure 22. Producer Shipments of GLP-1 Drugs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 23. Top 3 GLP-1 Drugs Manufacturer (Revenue) Market Share in 2025
Figure 24. Top 6 GLP-1 Drugs Manufacturer (Revenue) Market Share in 2025
Figure 25. Global GLP-1 Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 26. Global GLP-1 Drugs Consumption Value Market Share by Region (2021-2032)
Figure 27. North America GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 30. South America GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 32. Global GLP-1 Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 33. Global GLP-1 Drugs Consumption Value Market Share by Type (2021-2032)
Figure 34. Global GLP-1 Drugs Average Price by Type (2021-2032) & (US$/Unit)
Figure 35. Global GLP-1 Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 36. Global GLP-1 Drugs Revenue Market Share by Application (2021-2032)
Figure 37. Global GLP-1 Drugs Average Price by Application (2021-2032) & (US$/Unit)
Figure 38. North America GLP-1 Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 39. North America GLP-1 Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 40. North America GLP-1 Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 41. North America GLP-1 Drugs Consumption Value Market Share by Country (2021-2032)
Figure 42. United States GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 43. Canada GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 44. Mexico GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 45. Europe GLP-1 Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 46. Europe GLP-1 Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 47. Europe GLP-1 Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 48. Europe GLP-1 Drugs Consumption Value Market Share by Country (2021-2032)
Figure 49. Germany GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 50. France GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 51. United Kingdom GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 52. Russia GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 53. Italy GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 54. Asia-Pacific GLP-1 Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 55. Asia-Pacific GLP-1 Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 56. Asia-Pacific GLP-1 Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 57. Asia-Pacific GLP-1 Drugs Consumption Value Market Share by Region (2021-2032)
Figure 58. China GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 59. Japan GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 60. South Korea GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 61. India GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 62. Southeast Asia GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 63. Australia GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 64. South America GLP-1 Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 65. South America GLP-1 Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 66. South America GLP-1 Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 67. South America GLP-1 Drugs Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa GLP-1 Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 71. Middle East & Africa GLP-1 Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 72. Middle East & Africa GLP-1 Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 73. Middle East & Africa GLP-1 Drugs Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 75. Egypt GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 77. South Africa GLP-1 Drugs Consumption Value (2021-2032) & (USD Million)
Figure 78. GLP-1 Drugs Market Drivers
Figure 79. GLP-1 Drugs Market Restraints
Figure 80. GLP-1 Drugs Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of GLP-1 Drugs in 2025
Figure 83. Manufacturing Process Analysis of GLP-1 Drugs
Figure 84. GLP-1 Drugs Industrial Chain
Figure 85. Sales Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
